- Fund Type: SICAV
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
Dexia Equities B - Pharma Plus
+ Add to WatchlistCRE2489:BB
1,797.44 USD 10.07 0.56%As of 00:59:30 ET on 05/16/2013.
Snapshot for Dexia Equities B - Pharma Plus (CRE2489)
| Year To Date: | +20.99% | 3-Month: | +11.58% | 3-Year: | +16.12% | 52-Week Range: | 1,315.37 - 1,807.51 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +2.03% | 1-Year: | +33.89% | 5-Year: | +8.41% | Beta vs MXWO0HC: | 1.00 |
Fund Profile & Information for CRE2489
Dexia Equities B Pharma Plus is an open-end fund registered in Belgium. The objective is long-term growth and risk management through diversification. The Fund invest predominantly in US and European stocks of the pharmaceutical, healthcare, and biotechnology sectors. The Fund may also invests in options, warrants and futures. The benchmark is the MSCI World Health Care Index in USD.
| Inception Date: | 06-04-1997 | Telephone: | +32-2-222-11-11 |
|---|---|---|---|
| Managers: | RUDI VAN DEN EYNDE | ||
| Web Site: | www.dexia-am.com | ||
Fundamentals for CRE2489
| NAV | (on 2013-05-16) 1,797.44 |
|---|---|
| Assets (M) | (on 2013-05-16) 171.03 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for CRE2489
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Annual |
| Last Dividend Net | (on 2012-10-09) 30.00 |
| Dividend Yield (ttm) | 1.67 |
Fees & Expenses for CRE2489
| Front Load | 2.50 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 1.50 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | 1.80 |
Top Fund Holdings for CRE2489
Filing Date: 03/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Roche Holding AG | 44,000 | 10,268,758 | 7.024% |
| Johnson & Johnson | 123,000 | 10,028,190 | 6.860% |
| Pfizer Inc | 340,000 | 9,812,400 | 6.712% |
| Novartis AG | 117,000 | 8,333,756 | 5.701% |
| Merck & Co Inc | 146,000 | 6,457,580 | 4.417% |
| Sanofi | 59,000 | 6,005,646 | 4.108% |
| Bayer AG | 44,000 | 4,546,587 | 3.110% |
| GlaxoSmithKline PLC | 160,000 | 3,737,817 | 2.557% |
| Amgen Inc | 36,000 | 3,690,360 | 2.524% |
| Gilead Sciences Inc | 72,000 | 3,522,960 | 2.410% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page